FR
Contact
EquipeExpertise
ActualitésClassements & distinctionsPublications
À propos de nousCarrièreContact
de|fr|it|en
DEITEN
Contact
EquipeExpertise
ActualitésClassements & distinctionsPublications
À propos de nousCarrièreContact
de|fr|it|en
DEITEN
de|fr|it|en
Bâle Berne Binningen China Desk Genève Gstaad Japan Desk Lausanne Lugano Sion ZurichBâle Berne Binningen China Desk Genève Gstaad Japan Desk Lausanne Lugano Sion Zurich
  • Equipe
  • Expertise
  • Actualités
  • Classements & distinctions
  • Publications
  • À propos de nous
  • Carrière
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026
  • Equipe
  • Expertise
  • Actualités
  • Classements & distinctions
  • Publications
  • À propos de nous
  • Carrière
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026

Transactions & cas

Dr. Eliane Haas
  • Kellerhals Carrard with Seprify on Series A round and collaboration with Oterra Kellerhals Carrard with Seprify on Series A round and collaboration with Oterra 12 mars 2026
  • Kellerhals Carrard advises Vsquared Ventures on AlphaLum’s CHF 3.4 Million Seed Financing RoundKellerhals Carrard advises Vsquared Ventures on AlphaLum’s CHF 3.4 Million Seed Financing Round20 janvier 2026
  • Deal Ticker: Kellerhals Carrard supports Galenica to enter the diagnostics business by acquiring Labor TeamDeal Ticker: Kellerhals Carrard supports Galenica to enter the diagnostics business by acquiring Labor Team3 juillet 2025
  • Deal Ticker: Kellerhals Carrard advises TecMed on the Acquisition of Ypsomed Diabetes Care to Build Global Insulin PowerhouseDeal Ticker: Kellerhals Carrard advises TecMed on the Acquisition of Ypsomed Diabetes Care to Build Global Insulin Powerhouse22 avril 2025
  • Deal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AGDeal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AG13 mars 2025
  • Deal Ticker: Kellerhals Carrard advises Ego Death Capital on $12M Series A Funding Round for Relai Deal Ticker: Kellerhals Carrard advises Ego Death Capital on $12M Series A Funding Round for Relai 13 décembre 2024
  • Deal Ticker: Kellerhals Carrard advises Panakes Partners in the EUR 17.9 million Series B Financing Round of Lymphatica MedtechDeal Ticker: Kellerhals Carrard advises Panakes Partners in the EUR 17.9 million Series B Financing Round of Lymphatica Medtech16 octobre 2024
  • Orrick and Kellerhals Carrard for Partech in the Series C of xFarmOrrick and Kellerhals Carrard for Partech in the Series C of xFarm15 octobre 2024
  • Deal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AGDeal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AG28 juin 2024
  • Deal Ticker: Kellerhals Carrard Advises WellDev AG on Acquisition of InnoTix AGDeal Ticker: Kellerhals Carrard Advises WellDev AG on Acquisition of InnoTix AG7 mars 2024
  • Deal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AGDeal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AG9 août 2023
  • Dealticker - Orell Füssli acquires a majority stake in hep VerlagDealticker - Orell Füssli acquires a majority stake in hep Verlag8 juillet 2022